Sidique, Shyama published the artcileOrally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence, SDS of cas: 6797-79-1, the main research area is benzisothiazolone isoindolinone metabotropic glutamate receptor pos allosteric modulator preparation; structure activity relationship mGlu2 receptor modulator treatment nicotine dependence.
Compounds that modulate metabotropic glutamate subtype 2 (mGlu2) receptors have the potential to treat several disorders of the central nervous system (CNS) including drug dependence. Herein the authors describe the synthesis and structure-activity relationship (SAR) studies around a series of mGlu2 receptor pos. allosteric modulators (PAMs). The effects of N-substitution and substitutions on the aryl ring were identified as key areas for SAR exploration. Investigation of the effects of varying substituents in both the isoindolinone (I) and benzisothiazolone (II) series led to compounds with improved in vitro potency and/or efficacy. In addition, several analogs exhibited promising pharmacokinetic (PK) properties. Furthermore, compound I was shown to dose-dependently decrease nicotine self-administration in rats following oral administration. Our data, showing for the first time efficacy of an mGlu2 receptor PAM in this in vivo model, suggest potential utility for the treatment of nicotine dependence in humans.
Journal of Medicinal Chemistry published new progress about Allosterism. 6797-79-1 belongs to class chlorides-buliding-blocks, name is 4-Chloro-2-fluoroiodobenzene, and the molecular formula is C6H3ClFI, SDS of cas: 6797-79-1.
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics